- $3.80bn
- $4.15bn
- $949.25m
- 85
- 31
- 38
- 50
Annual income statement for Novanta, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 591 | 707 | 861 | 882 | 949 |
| Cost of Revenue | |||||
| Gross Profit | 245 | 300 | 378 | 400 | 422 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 535 | 643 | 758 | 771 | 839 |
| Operating Profit | 55.9 | 64.1 | 103 | 110 | 111 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 48.4 | 56.2 | 87.2 | 83.7 | 79.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 44.5 | 50.3 | 74.1 | 72.9 | 64.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 44.5 | 50.3 | 74.1 | 72.9 | 64.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 44.5 | 50.3 | 74.1 | 72.9 | 64.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.35 | 1.86 | 2.17 | 2.39 | 2.08 |